Le Lézard
Classified in: Health
Subjects: PDT, SVY, TRI, SBS

Study Reveals Exciting Benefits of Using a Low Dose Valerian Extract for Sleep Quality and Occasional Anxiety


BRIDGEWATER, N.J. and MUMBAI, India, Nov. 1, 2023 /PRNewswire/ -- A new study by OmniActive Health Technologies, an innovative, scientifically validated, and nature-based company that provides ingredients to nutrition brands around the world, today unveiled the effects of using its proprietary ingredient, Sleeproot, a standardized and differentiated valerian extract, to improve sleep quality and manage occasional anxiety. Published in Advances in Therapy, the study's goal was to assess the efficacy of Sleeproot in promoting aspects of sleep quality and reducing feelings of anxiety.

The study revealed that Sleeproot significantly improved sleep quality scores based on the Pittsburgh Sleep Quality Index questionnaire, as well as:

"These findings represent an innovative plant-based approach to managing occasional sleep and anxiety issues," said Deshanie Rai, PhD, FACN, VP, Global Scientific, and Regulatory Affairs at OmniActive. "This study shows that Sleeproot, a low dose valerian extract, at a 2% valerenic acid potency, can significantly improve aspects of sleep quality, as measured by validated quantitative and qualitative sleep methodologies."

The randomized, double-blind, placebo-controlled trial involving seventy-two healthy male and female adults, between the ages of 21-48 years old, who experienced sleep issues. Over a period of 8 weeks, participants were administered Sleeproot in a capsule format, with a daily dose of 200 mg taken one hour before bedtime. The research included regular study visits to monitor outcomes related to sleep quality and occasional anxiety.

Using a combination of validated sleep assessment tools, including the Pittsburgh Sleep Quality Index, Wrist Actigraphy, and Polysomnography, researchers measured various parameters of sleep quality. These parameters included sleep latency, sleep duration, sleep efficiency, daytime sleepiness, and the feeling of being refreshed upon waking. Additionally, the Beck Anxiety Index was used to assess feelings related to occasional anxiety.

"These findings show that Sleeproot can offer a non-hormonal approach for those seeking to improve sleep quality and a natural way to manage occasional anxiety," says Kratika Gupta, Global Marketing Lead at OmniActive. "This ingredient's unique benefits and safety profile positions Sleeproot as a perfect plant-based alternative to conventional interventions, catering to wellness companies that are seeking a comprehensive natural solution for sleep and anxiety concerns."

To learn more about Sleeproot and the process and formulation technology visit omniactives.com.

About OmniActive
Established in 2005, OmniActive Health Technologies seeks to improve lives through innovative science and natural health solutions. OmniActive's product portfolio consists of scientifically validated, IP-protected, branded Specialty Actives and an extensive portfolio of natural Botanical Actives for global customers in the dietary supplement, functional food, and beverage markets. OmniActive partners closely with its customers in key markets worldwide and is supported by three global R&D centers and best-in-class production facilities throughout India. The company has offices in Mumbai, India, and Bridgewater, New Jersey.

Media Contact
Meredith Kish
[email protected]
+1-973-202-4034

Sarah Sullivan
[email protected]
+1-443-651-9724

SOURCE OmniActive


These press releases may also interest you

at 09:46
As the nation kicks off National Nurses Week (May 6 ? 12) a...

at 09:42
In the realm of employee benefits, the trend towards self?funded healthcare is unmistakable, as the regulatory landscape continues to change and healthcare costs continue to escalate. The National Association of Insurance Commissioners estimates that...

at 09:40
Quest Diagnostics , a leading provider of diagnostic information services, announced today that Murali Balakumar, a veteran information technology healthcare business leader, has been named Senior Vice President and Chief Information and Digital...

at 09:35
Seres Therapeutics, Inc. , a leading microbiome therapeutics company, today announced that management will host a conference call and live audio webcast on May 8, 2024 at 8:30 a.m. ET to discuss first quarter 2024 financial results and provide...

at 09:30
The Prime Minister, Justin Trudeau, today issued the following statement on National Nursing Week, which runs from May 6 to 12: "Today, as we mark the start of National Nursing week, I join Canadians across the country to celebrate our nurses, their...

at 09:30
CG Pharmaceuticals, a late-stage clinical biopharmaceutical company specializing in metastatic pancreatic ductal adenocarcinoma (PDAC) maintenance therapy (NCT05249101), will feature one of our investigators, Dr. Christos Fountzilas from Roswell Park...



News published on and distributed by: